Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
EBIATMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsReceivables - Other
Ratios

CervoMed (CRVO) EBIAT (2022 - 2025)

CervoMed's EBIAT history spans 9 years, with the latest figure at -$7.7 million for Q3 2025.

  • For Q3 2025, EBIAT fell 62.54% year-over-year to -$7.7 million; the TTM value through Sep 2025 reached -$25.6 million, down 114.15%, while the annual FY2024 figure was -$16.3 million, 650.08% down from the prior year.
  • EBIAT for Q3 2025 was -$7.7 million at CervoMed, down from -$6.3 million in the prior quarter.
  • Across five years, EBIAT topped out at $2.2 million in Q3 2023 and bottomed at -$7.7 million in Q3 2025.
  • The 4-year median for EBIAT is -$2.8 million (2022), against an average of -$3.3 million.
  • The largest annual shift saw EBIAT soared 176.84% in 2023 before it crashed 370.55% in 2024.
  • A 4-year view of EBIAT shows it stood at -$1.5 million in 2022, then tumbled by 54.67% to -$2.4 million in 2023, then crashed by 183.86% to -$6.7 million in 2024, then decreased by 15.22% to -$7.7 million in 2025.
  • Per Business Quant, the three most recent readings for CRVO's EBIAT are -$7.7 million (Q3 2025), -$6.3 million (Q2 2025), and -$4.9 million (Q1 2025).